Dr. Morris D. Groves Jr. is a Austin, Texas based neurologist who is specialized in Clinical Neurophysiology. His current practice location is 901 W 38th St Ste 200, Austin. Patients can reach him at 512-421-4100 or can fax him at 512-454-4575. Dr. Morris D. Groves Jr. is MD in Clinical Neurophysiology and his NPI number (Unique professional ID assigned by NPPES) is 1467545004. Dr. Morris D. Groves Jr. is subspecialized with psychiatric or neurologic expertise in the diagnosis and management of central, peripheral, and autonomic nervous system disorders using combined clinical evaluation and electrophysiologic testing such as electroencephalography (EEG), electromyography (EMG), and nerve conduction studies (NCS).
Complete Profile:
Dr. Morris D. Groves Jr. speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Dr. Morris D. Groves Jr.
Specialization:
Clinical Neurophysiology
Gender:
Male
Credentials:
MD
Practice Address:
901 W 38th St Ste 200, Austin, Texas, 78705-1165
Phone:
512-421-4100
Fax:
512-454-4575
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1467545004
NPI Enumeration Date:
02 Oct, 2006
NPI Last Update On:
11 Feb, 2013
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Morris D. Groves Jr. Po Box 911230, Dallas, Texas
Zip:
75391-1230
Phone Number:
972-997-8000
Fax Number:
972-234-2987
Patients can reach Dr. Morris D. Groves Jr. at 901 W 38th St Ste 200, Austin, Texas or can call to book an appointment on 512-421-4100.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.